Patent US4352805A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4352805A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods of treating psychosis

Assignee: Pharmacia and Upjohn Co
•
Filing: 1980-10-10
•
Granted: 1982-10-05
•
Expires: 2000-10-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Isochromans, isothiochromans, 2-benzoxepins and 2-benzothiepins are described. The compounds possess hypotensive and antipsychotic properties; methods and compositions using them are described.

Inventors

  • 👤 John M. McCall

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 10:47
CPC Classifications
C; C07; C07D; C07D337/00; C07D337/02; C07D337/06; C07D337/08; C07C; C07C43/00; C07C43/02; C07C43/20; C07C43/23; C07D311/00; C07D311/02; C07D311/74; C07D313/00; C07D313/02; C07D313/06; C07D313/08; C07D335/00; C07D335/04; C07D335/06

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 18 words
A method of treating psychosis in humans which comprises administering systemically to humans an antipsychotic dose of 2-[(1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzoxepin-1-yl)methyl]-4-(2-pyridyl)piperazine.
Claim 2
Independent Claim 18 words
A method of treating psychosis in humans which comprises administering systemically to humans an antipsychotic dose of 2-[(1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzoxepin-1-yl)methyl]-4-(2-pyridyl)piperazine.
Claim 3
Independent Claim 18 words
A method of treating psychosis in humans which comprises administering systemically to humans an antipsychotic dose of 2-[(1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzoxepin-1-yl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline.
Claim 4
Independent Claim 18 words
A method of treating psychosis in humans which comprises administering systemically to humans an antipsychotic dose of 2-[(1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzoxepin-1-yl)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-10-04 1986-04-05 1986-10-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-10-04 1990-04-05 1990-10-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-10-04 1994-04-05 1994-10-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag